| 11C | carbone-11 |
| 18F | flour-18 (fluorine-18) |
| 18F-FDG | 18F-Fluorodeoxyglucose |
| AUA | The American Urological Association |
| BCR | biochemical recurrence |
| BRFS | biochemical relapse-free survival |
| CI | confidence interval |
| CT | computed tomography |
| DWI | diffusion-weighted imaging |
| EAU | The European Association of Urology |
| ePLND | extended pelvic lymph node dissection |
| FDA | The United States Food and Drug Administration |
| HR | hazard ratio |
| ICG | Indo-cyanine green |
| IQR | interquartile range |
| LN | lymph node |
| LND | lymph node dissection |
| LNI | lymph node invasion |
| lPLND | limited pelvic lymph node dissection |
| MFS | metastasis-free survival |
| MRI | magnetic resonance imaging |
| MSKCC | Memorial Sloan Kettering Cancer Center |
| NAAALDASE | N-acetyl-aspartyl-glutamate peptidase |
| NCCN | The National Comprehensive Cancer Network |
| NICE | The National Institute for Health and Care Excellence |
| PCa | prostate cancer |
| PET | positron emission tomography |
| PLND | pelvic lymph node dissection |
| PSA | prostate-specific antigen |
| PSMA | prostate-specific membrane antigen |
| RARP | robot assisted radical prostatectomy |
| RCT | randomized controlled trial |
| RGS | radio-guided surgery |
| RP | radical prostatectomy |
| RRP | retropubic radical prostatectomy |
| SLND | sentinel lymph node dissection |
| SN | sentinel node |
| SNNS | sentinel node navigation surgery |
| SPECT | single-photon emission computed tomography |
| SPIO | supermagnetic iron oxide |
| sPLND | sentinel pelvic lymph node dissection |